Aker BioMarine
AKBM | OL
Overview
Corporate Details
- ISIN(s):
- NO0010886625 (+1 more)
- LEI:
- 549300V34T6VWDSYWE64
- Country:
- Norway
- Address:
- Oksenøyveien 10, 1366 Lysaker
- Website:
- https://www.akerbiomarine.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of vegetable and animal oils and fats
Description
Aker BioMarine is a biotechnology innovator and the world's leading supplier of krill-based ingredients sourced from the Antarctic. The company specializes in the research, development, and manufacturing of krill-derived products for the human health and nutrition markets, with a focus on nutraceutical applications like omega-3 supplements. A key differentiator is its vertically integrated value chain, which ensures full traceability and control from sustainable harvesting in the Southern Ocean to the final ingredient. Aker BioMarine leverages scientific research to develop its portfolio of natural ingredients.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Aker BioMarine and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-10 13:55 |
Interest Rate Update/Notice
Rentefastsettelse - Attachment: adcf0c6edcec4d98a172592dc9018192.pdf
|
Norwegian | 44.0 KB | |
| 2025-09-10 13:55 |
Interest Rate Update/Notice
Rentefastsettelse
|
Norwegian | 532 bytes | |
| 2025-07-18 14:55 |
Director's Dealing
AKBM: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER - Attachment: Skjema f…
|
Norwegian | 130.4 KB | |
| 2025-07-18 14:55 |
Director's Dealing
AKBM: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER
|
English | 1.7 KB | |
| 2025-07-11 07:00 |
Interim Report
Second quarter 2025 results for Aker BioMarine - Attachment: AKBM 1H report 202…
|
English | 1.2 MB | |
| 2025-07-11 07:00 |
Investor Presentation
Second quarter 2025 results for Aker BioMarine - Attachment: Aker BioMarine Q2 …
|
English | 1.4 MB | |
| 2025-07-11 07:00 |
Earnings Release
Second quarter 2025 results for Aker BioMarine
|
English | 4.1 KB | |
| 2025-06-20 16:48 |
Capital/Financing Update
Euronext Oslo Børs – Aker BioMarine ASA - Mottatt søknad om notering av obligas…
|
Norwegian | 572 bytes | |
| 2025-06-20 16:48 |
Regulatory News Service
Euronext Oslo Børs – Aker BioMarine ASA - Received application for listing of b…
|
Norwegian | 622 bytes | |
| 2025-06-16 14:00 |
Prospectus
Aker BioMarine ASA – Base prospectus approved for listing of bonds - Attachment…
|
English | 2.3 MB | |
| 2025-06-16 14:00 |
Prospectus
Aker BioMarine ASA – Base prospectus approved for listing of bonds
|
English | 1.8 KB | |
| 2025-05-02 12:45 |
Director's Dealing
Mandatory notification of trade
|
Norwegian | 129.3 KB | |
| 2025-05-02 12:45 |
Director's Dealing
Mandatory notification of trade
|
English | 1.4 KB | |
| 2025-04-30 05:00 |
Investor Presentation
First quarter 2025 results for Aker BioMarine
|
English | 1.4 MB | |
| 2025-04-30 05:00 |
Earnings Release
First quarter 2025 results for Aker BioMarine
|
English | 4.3 KB |
Automate Your Workflow. Get a real-time feed of all Aker BioMarine filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Aker BioMarine via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
